Resources for Journalists

COVID-19 is a disease caused by the SARS-CoV-2 virus strain, that has not been previously identified in humans. See below for a collection of resources to help you cover this issue (Please note: additional resources are available to journalists who are logged in).

The AusSMC also issues a daily COVID-19 update for registered journalists (click here to view an example). If you would like to receive this email, please go to your profile on MyScimex and select yes beside "Receive COVID-19 Updates?". The email update and this resources page are supported by the Google News Initiative.

Latest COVID-19 news, research, expert reactions and briefings

Show/Hide newsfeed filter Filter by
Type
News for

Choose a location of interest

  1. Delta may be 133% more deadly than the original COVID-19 strain

    Publicly released: Tue 5 Oct 2021 at 1100 AEDT, 1300 NZDT

    Canadian Medical Association Journal

    The Delta variant of COVID-19 appears to increase the risk of death by 133 per cent compared to the original strain of the virus, and the chance of ICU admission ... The emergence of novel SARS-CoV-2 VOCs Read more about Delta may be 133% more deadly than the original COVID-19 strain

    InternationalUniversity of Toronto, Canada

  2. 2 doses of the Pfizer COVID-19 jab could keep you out of the hospital for 6 months

    Publicly released: Tue 5 Oct 2021 at 0930 AEDT, 1130 NZDT

    The Lancet

    4, 2020, and Aug. 8, 2021, to assess BNT162b2 vaccine effectiveness against SARS-CoV-2 infections and COVID-19-related hospitalization. ... A whole genome sequencing and viral lineage analysis of 8,911 PCR Read more about 2 doses of the Pfizer COVID-19 jab could keep you out of the hospital for 6 months

    InternationalKaiser Permanente, USA

  3. Bone-conducting headphones could be better than grommets

    Publicly released: Tue 5 Oct 2021 at 0930 AEDT, 1130 NZDT

    BMJ Innovations

    The parents of 26 children diagnosed with glue ear and/or scheduled for grommet insertion in the local area during the first wave of the 2020 COVID-19 pandemic in the ... glue ear and its resulting Read more about Bone-conducting headphones could be better than grommets

    InternationalCambridgeshire Community Services NHS Trust, UK

  4. Parents of children with chronic lung conditions concerned with safety and side effects of COVID-19 vaccine

    Publicly released: Tue 5 Oct 2021 at 0857 AEDT, 1057 NZDT

    Health Science Reports

    Parents of children with chronic lung conditions want their children to get the COVID-19 vaccine but they are concerned with the safety and side effects of the COVID-19 vaccine ... With the emergence of Read more about Parents of children with chronic lung conditions concerned with safety and side effects of COVID-19 vaccine

    Australia; NSWThe University of New South Wales

  5. Landmark trial eliminates pest mosquito

    Publicly released: Tue 5 Oct 2021 at 0600 AEDT, 0800 NZDT

    PNAS

    The creation of our Health and Biosecurity team back in 2016 meant we were prepared for COVID-19, and that preparation is paying off across other biosecurity threats like mosquitos which ... The technique Read more about Landmark trial eliminates pest mosquito

    Australia; International; QLDCSIRO | James Cook University | QIMR Berghofer Medical Research Institute ...

  6. Serious heart problems from mRNA vaccines are really rare

    Publicly released: Tue 5 Oct 2021 at 0200 AEDT, 0400 NZDT

    JAMA Internal Medicine

    4 million Americans who’d had at least one dose of a COVID-19 mRNA vaccine. ... The authors say this study is unique in its ethnic diversity, and in reflecting real-world practice. Read more about Serious heart problems from mRNA vaccines are really rare

    InternationalKaiser Permanente Los Angeles Medical Center, Kaiser Permanente Southern California,Kaiser Permanente Orange County Medical Center, US

  7. EXPERT Q&A: Is Merck’s COVID-19 pill molnupiravir a game-changer?

    Publicly released: Tue 5 Oct 2021 at 0100 AEDT, 0300 NZDT

    The Federal government has bought 300,000 doses of Merck COVID-19 treatment drug molnupiravir, although it has not yet been approved by the TGA as a COVID-19 treatment. ... On Friday the manufacturer Read more about EXPERT Q&A: Is Merck’s COVID-19 pill molnupiravir a game-changer?

    Australia; International; VICMonash University

  8. NZ-made app for Covid wellbeing helps with stress and anxiety

    Publicly released: Mon 4 Oct 2021 at 1312 AEDT, 1512 NZDT

    Internet Interventions

    University of Auckland researchers have tested whether a wellbeing app they rapidly made at the start of the pandemic helped young people cope a little better. ... They found significant improvements in Read more about NZ-made app for Covid wellbeing helps with stress and anxiety

    New ZealandUniversity of Auckland | Counties Manukau Health; Tamaki Health; Auckland District Health Board

  9. Breakfast beers and Zoom wine: How COVID-19 changed our drinking patterns and styles

    Publicly released: Mon 4 Oct 2021 at 0300 AEDT, 0500 NZDT

    Drug and Alcohol Review

    COVID-19 restrictions have led to shifts in the when and why of Aussie drinking behaviour, according to Aussie research. ... But the fact that many of us shifted to being at home more, and some lost their Read more about Breakfast beers and Zoom wine: How COVID-19 changed our drinking patterns and styles

    Australia; VIC; WALa Trobe University | Curtin University | The University of Melbourne

  10. Getting off screens and getting active can help kids' mental health during the pandemic

    Publicly released: Sat 2 Oct 2021 at 0100 AEST, 0400 NZDT

    JAMA Network Open

    After accounting for variations in COVID-19 impacts on families, the study found that younger kids who did 60 minutes of physical activity seven days a week had better mental health ... S. children during Read more about Getting off screens and getting active can help kids' mental health during the pandemic

    InternationalSeattle Children’s Research Institute, USA

  11. 1 in 3 have long Covid 3 to 6 months after getting infected

    Publicly released: Fri 1 Oct 2021 at 0806 AEST, 1106 NZDT

    PLOS Medicine

    Analysing electronic health records from more than 273,000 US patients with Covid-19, researchers found 37% had one or more long Covid symptoms recorded between 3 and 6 months after ... This study sheds Read more about 1 in 3 have long Covid 3 to 6 months after getting infected

    InternationalUniversity of Oxford, TriNetX Inc., National Institute for Health Research, UK

  12. Communicating the potential to prevent death may help shift vaccine hesitancy

    Publicly released: Fri 1 Oct 2021 at 0100 AEST, 0400 NZDT

    JAMA Network Open

    A survey of 2,556 Canadian adults compared communication strategies to reduce hesitance toward two less-popular COVID-19 vaccines - AstraZeneca and Johnson & Johnson. ... Conversely, people who received Read more about Communicating the potential to prevent death may help shift vaccine hesitancy

    InternationalUniversity of Toronto, Canada

  13. Large trial suggests AstraZeneca COVID-19 jab is safe and effective

    Publicly released: Thu 30 Sep 2021 at 0700 AEST, 1000 NZDT

    NEJM

    A 'gold standard' clinical trial of the AstraZeneca COVID-19 jab in 32,451 participants from the US, Chile, and Peru found the vaccine is safe and effective in adults, including ... The scientists say Read more about Large trial suggests AstraZeneca COVID-19 jab is safe and effective

    InternationalAstraZeneca

  14. REGEN-COV antibody combo cuts COVID-19 hospitalisations and deaths

    Publicly released: Thu 30 Sep 2021 at 0700 AEST, 1000 NZDT

    NEJM

    A US trial of REGEN-COV, a combination of the COVID-19 antibodies casirivimab and imdevimab, in 2,696 COVID-19 patients found the antibody treatment cut the risk of death ... The treatment also cut the Read more about REGEN-COV antibody combo cuts COVID-19 hospitalisations and deaths

    InternationalRegeneron Pharmaceuticals, USA

  15. One pandemic in the UK, but diverging experiences

    Publicly released: Thu 30 Sep 2021 at 0400 AEST, 0700 NZDT

    PLOS ONE

    The Covid-19 pandemic has had varying impacts on people’s income, time use and well-being, depending on gender and ethnicity. ... Differential effects of UK COVID-19 lockdowns tracked across social Read more about One pandemic in the UK, but diverging experiences

    InternationalUniversity of Oxford (UK), Hong Kong University of Science and Technology (Guangzhou, China)

  16. US vaccine rollouts by age prevent twice as many white deaths as Black deaths

    Publicly released: Thu 30 Sep 2021 at 0400 AEST, 0700 NZDT

    Science Advances

    This study analyzed how hypothetical vaccination plans could affect COVID-19 mortality and equity in California and Minnesota, 2 demographically divergent states. ... risk of exposure to SARS-CoV-2 is Read more about US vaccine rollouts by age prevent twice as many white deaths as Black deaths

    InternationalUniversity of Minnesota, Stanford University, Harvard University, University of California San Francisco, University of California, Berkeley (USA), and French Institute for Demographic Studies, France

  17. Aussie GPs have concerns about keeping safe from COVID-19

    Publicly released: Thu 30 Sep 2021 at 0001 AEST, 0301 NZDT

    Australian Journal of Primary Health

    GPs said they needed more information, education and resources on vaccines to help them manage their role in the COVID-19 pandemic, which they saw as being to educate the public, ... correct Read more about Aussie GPs have concerns about keeping safe from COVID-19

    Australia; NSW; QLDThe University of Sydney | The University of Queensland

  18. Melbourne-made COVID-19 treatment could future-proof Australia

    Publicly released: Wed 29 Sep 2021 at 1530 AEST, 1830 NZDT

    Cell Reports

    Scientists found antibodies that blocked the SARS-CoV-2 virus from entering cells in preclinical models. ... Antibodies from recovered COVID-19 patients and CSL’s proprietary antibody library were used Read more about Melbourne-made COVID-19 treatment could future-proof Australia

    Australia; VICWEHI

  19. Drugs that make COVID-19 even a little less contagious could have a big impact on the pandemic

    Publicly released: Wed 29 Sep 2021 at 0901 AEST, 1201 NZDT

    Journal of the Royal Society Interface

    The authors modelled what features of potential drug treatments would have the greatest influence on stopping the COVID-19 pandemic and found that starting treatment early is the key. ... A modelling Read more about Drugs that make COVID-19 even a little less contagious could have a big impact on the pandemic

    InternationalUniversité de Picardie Jules Verne, France

  20. Why do fewer young adults follow the rules on COVID-19 prevention?

    Publicly released: Wed 29 Sep 2021 at 0901 AEST, 1201 NZDT

    Royal Society Open Science

    Against expectations, the age variation wasn’t explained by differences in the objective risk of Covid-19 complications, or attitudes toward risk. ... The authors speculate that being better with Read more about Why do fewer young adults follow the rules on COVID-19 prevention?

    InternationalUniversity of Essex, UK; University of Edinburgh, UK

Show Results

  1. 10
  2. 20
  3. 50